Alpha 2.0
Login Register
» Articles » PMID: 21830231

Prognostic Significance of Delayed Thrombocytopenia After Allogeneic Stem Cell Transplant

Overview
Journal Am J Hematol
Specialty Hematology
Date 2011 Aug 11
PMID 21830231
Citations 8
Authors
Francesco Zaja
Antonella Geromin
Francesca Patriarca
Simona Puglisi
Michela Cerno
Alessandra Sperotto
Marta Lisa Battista
Miriam Isola
Renato Fanin
Affiliations
Soon will be listed here.
Citing Articles

Thrombopoietin Receptor Agonists in Post-Hematopoietic Cell Transplantation Complicated by Prolonged Thrombocytopenia: A Comprehensive Review.

Elsayed A, Elsayed B, Elmarasi M, Elsabagh A, Elsayed E, Elmakaty I Immunotargets Ther. 2024; 13:461-486.

PMID: 39290805 PMC: 11407319. DOI: 10.2147/ITT.S463384.

Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation.

Zhou M, Li T, Zhang P, Lai Y, Sheng L, Ouyang G Ann Hematol. 2024; 103(5):1697-1704.

PMID: 38536476 DOI: 10.1007/s00277-024-05711-1.

Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.

Fraint E, Farooki S, Klein E, Mauguen A, Prockop S, Scaradavou A Transplant Cell Ther. 2022; 29(1):46.e1-46.e6.

PMID: 36210027 PMC: 9825630. DOI: 10.1016/j.jtct.2022.09.027.

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.

Karatas A, Goker H, Demiroglu H, Malkan U, Velet M, Cinar O Turk J Med Sci. 2022; 52(2):413-419.

PMID: 36161632 PMC: 10381231. DOI: 10.55730/1300-0144.5328.

Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation.

Zhu L, Liu J, Kong P, Gao S, Wang L, Liu H Front Immunol. 2022; 13:910893.

PMID: 35693772 PMC: 9184517. DOI: 10.3389/fimmu.2022.910893.